Rachel Frizberg

Roche Pharma

Global Product Strategy (GPS) Therapeutic Area Head for Immunology, Infectious Diseases and Ophthalmology.

Rachel Frizberg has worked in the pharmaceutical industry for more than 20 years and has held various positions both in the UK and Globally.  She started her career at Glaxo Wellcome in the UK in 1993 and subsequently moved to Ferring Pharmaceuticals and then Sanofi Aventis, where she gained extensive product launch and strategy development experience with specialist hospital and primary care products.

Since joining Roche Pharma in May 2006, she has worked in more than 10 different therapeutic areas. Rachel moved to Asia in 2012, supporting Roche’s mission to make healthcare more sustainable and medicines more accessible in the region. While working in Hong Kong in 2014, she was the President of the Hong Kong Association of The Pharmaceutical Industry and successfully launched an Oncology Innovation Study Group to enable a Cancer Strategy being put in place for Hong Kong.

Rachel spent 5 years in Asia working with decision makers to develop strategies to improve healthcare systems. She moved into her current role as Area Head in 2018 where she enables and supports regional healthcare systems to adapt a patient-centric approach. She is passionate about igniting cross-sector, international collaboration to drive a personalised approach to health that will deliver improvement in patient wellbeing and ultimately have an impact on population health.

Rachel studied Business and Finance at Oxford Brookes University and also holds a Diploma in Marketing from the Chartered Institute of Marketing.